Economic Burden pilot study

This two-year infrastructure pilot study will use data from four sites to estimate the cancer-related pharmacy costs among aged Medicare HMO beneficiaries who were omitted from SEER-Medicare data due to the exclusion of outpatient medication use/cost. The investigative team will test the hypothesis that SEER-Medicare data undercount the full economic burden of cancer care in the U.S., because of incomplete coverage of outpatient prescribed medications for aged Medicare beneficiaries. A byproduct of this research will be the development of a reusable infrastructure that will enhance the CRN VDW for other uses, including efforts focused on the dissemination of pharmacotherapy among cancer

patients. This pilot study complements the R01 project, Medical Burden of Cancer: System and Data Issues.

<< Back to the list of CRN projects